Bayer Makes News With Baycol Recall And Profit Warning

August 2001
Chemical Market Reporter;8/13/2001, Vol. 260 Issue 7, p1
Trade Publication
Reports on the business of Bayer AG. Decision of the company to withdraw its cholesterol-lowering drug in the market; Decline in the operating profit of the company during the first half of 2001.


Related Articles

  • Bayer opens largest TDA plant. Gordon, Michael // European Chemical News;12/8/2003, Vol. 79 Issue 2080, p10 

    States that Bayer has opened a toluene diamine (TDA) plant in Dormagen, Germany. Production capacity of the plant; Aim of the company in building the plant; Investment of the company in the plant; Details on the plans of the company; Comments from officials of the company.

  • Bayer faces first year loss. Beacham, Will // European Chemical News;12/22/2003, Vol. 79 Issue 2081, p9 

    Reports on the loss posted by Bayer as of January 11, 2004. Reason behind the loss reported by the company; Information on the asset impairment charge of Bayer; Plan of Bayer to close its urology research center in Kyoto, Japan.

  • Bayer's Journey. Hunter, David // Chemical Week;2/6/2002, Vol. 164 Issue 5, p5 

    Provides information on Bayer AG in the United States as of February 6, 2002. Annual sales of the health care and crop protection business of Bayer; Value of Bayer's polymers business; Presentation of the top management during its New York Stock Exchange listing in January 2002.

  • Bayer Plastics/Chemicals Unit to Be Called Lanxess.  // Plastics Technology;May2004, Vol. 50 Issue 5, p76 

    Reports on the plan of Bayer AG to spin off a large part of its chemicals and plastics businesses into a publicly held company to be called Lanxess. Product portfolio of Lanxess.

  • Bayer rejigs chemicals division into new units.  // Chemical Business;Aug98, Vol. 12 Issue 8, p143 

    Reports that Bayer AG will reorganize its chemicals division into three units. Benefits from the improved structure; Transfer of titanium oxides and silicones activities to joint ventures with United States partners.

  • Bayer Stands Firm on Strategy. Hume, Claudia // Chemical Week;4/11/2001, Vol. 163 Issue 15, p35 

    Focuses on the business strategy of Bayer company. Motion to separate the company into three units; Need for the company to make acquisitions; Information on its herbicide and pesticide products; Plans for the pharmaceutical and polymer businesses; Possible sale of its chemical division.

  • Bayer sales in China reach new highs. Oey, Patricia // Chemical Market Reporter;04/13/98, Vol. 253 Issue 15, p20 

    Reports on Bayer AG's 1997 sales in the chemicals market in China. Annual growth rate; Bayer's joint ventures with other chemical manufacturers in the country.

  • Bayer is confident on Asian growth and proceeding with spending...  // Chemical Market Reporter;12/01/97, Vol. 252 Issue 22, p9 

    Focuses on the expectations of Bayer AG on the future growth of the chemical industry in the Asia Pacific. Financial plans of the company for 2010; Financial data of the company in the third quarter of 1997; Status of the global business of Bayer.

  • More Taiwan protests against Bayer.  // Chemical Week;2/25/1998, Vol. 160 Issue 7, p8 

    Reports that a group of demonstrators protested at the provincial assembly building in Taichung, Taiwan as a special task force inside debated Bayer's toluene diisocyanate project. Reasons why Bayer suspended the project after the protests in 1997; Reason for the visit of Taiwanese lawmakers and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics